These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 31832993)

  • 101. Androgens in women: Androgen-mediated skin disease and patient evaluation.
    Bienenfeld A; Azarchi S; Lo Sicco K; Marchbein S; Shapiro J; Nagler AR
    J Am Acad Dermatol; 2019 Jun; 80(6):1497-1506. PubMed ID: 30312644
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Clascoterone: a new topical anti-androgen for acne management.
    Santhosh P; George M
    Int J Dermatol; 2021 Dec; 60(12):1561-1565. PubMed ID: 34242398
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Hair regrowth. Therapeutic agents.
    Shapiro J; Price VH
    Dermatol Clin; 1998 Apr; 16(2):341-56. PubMed ID: 9589208
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Topical Minoxidil: Systematic Review and Meta-Analysis of Its Efficacy in Androgenetic Alopecia.
    Gupta AK; Charrette A
    Skinmed; 2015; 13(3):185-9. PubMed ID: 26380504
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial.
    Gruber DM; Sator MO; Joura EA; Kokoschka EM; Heinze G; Huber JC
    Arch Dermatol; 1998 Apr; 134(4):459-63. PubMed ID: 9554298
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
    Shapiro J; Kaufman KD
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Promising therapies for treating and/or preventing androgenic alopecia.
    McElwee KJ; Shapiro JS
    Skin Therapy Lett; 2012 Jun; 17(6):1-4. PubMed ID: 22735503
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Prescribing Habits for Androgenic Alopecia among Dermatologists in Spain in 2019-2020: A Cross-Sectional Study.
    Pindado-Ortega C; Saceda-Corralo D; Fernández-Nieto D; Jiménez-Cauhé J; Ortega-Quijano D; Moreno-Arrones ÓM; Vañó-Galván S
    Skin Appendage Disord; 2020 Sep; 6(5):283-286. PubMed ID: 33088813
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Efficacy comparison of monotherapies and combination therapies for androgenetic alopecia: A Bayesian network meta-analysis.
    Chen D; Yang X; Liu X; He Y; Fan W; Wang H; Lin Y
    Dermatol Ther; 2022 Mar; 35(3):e15262. PubMed ID: 34897933
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Topical finasteride dose evaluation for treatment of androgenetic alopecia using computer simulations.
    Todeschini D; Pedro Martinez IC; Dutra Duque M
    Ann Pharm Fr; 2022 Mar; 80(2):169-175. PubMed ID: 34425076
    [TBL] [Abstract][Full Text] [Related]  

  • 111. A Phase 1 Study to Investigate the Effects of Cortexolone 17α-Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity.
    Täubel J; Mazzetti A; Ferber G; Burch W; Fernandes S; Patel A; Spencer CS; Freier A; Graff C; Kanters JK; Camm J
    Clin Pharmacol Drug Dev; 2021 Jun; 10(6):572-581. PubMed ID: 33942574
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Histone deacetylase 1 in patients with alopecia areata and acne vulgaris: An epigenetic alteration.
    Abdelkader HA; Amin I; Rashed LA; Samir M; Ezzat M
    Australas J Dermatol; 2022 May; 63(2):e138-e141. PubMed ID: 35076083
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Applications of Gold and Silver Nanoparticles in the Treatment of Acne Vulgaris: A Systematic Review.
    Artounian K; Bundogji N; Hoss E; Boen M
    J Drugs Dermatol; 2021 Jun; 20(6):666-670. PubMed ID: 34076399
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Acne Vulgaris in Skin of Color: A Systematic Review of the Effectiveness and Tolerability of Current Treatments.
    Pathmarajah P; Peterknecht E; Cheung K; Elyoussfi S; Muralidharan V; Bewley A
    J Clin Aesthet Dermatol; 2022 Nov; 15(11):43-68. PubMed ID: 36381183
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream.
    Sanchez C; Keri J
    Clin Cosmet Investig Dermatol; 2022; 15():1357-1366. PubMed ID: 35874458
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients.
    Rossi A; Magri F; D'Arino A; Pigliacelli F; Muscianese M; Leoncini P; Caro G; Federico A; Fortuna MC; Carlesimo M
    Dermatol Pract Concept; 2020; 10(2):e2020039. PubMed ID: 32363101
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Insights of Lipid Vesicular and Particulate Carrier Mediated Approach for Acne Management.
    Dudhat S; Singh P; Pimple P
    Curr Drug Deliv; 2022; 20(1):57-74. PubMed ID: 35611775
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Mechanistic support of traditional Persian medicine for the treatment of acne vulgaris: A scoping review.
    Pasalar M; Tabatabaei F; Bradley R; Tajadini H; Kamali M; Hasheminasab FS; Parvizi MM
    J Cosmet Dermatol; 2022 Jun; 21(6):2338-2348. PubMed ID: 34564932
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review.
    Ly S; Kamal K; Manjaly P; Barbieri JS; Mostaghimi A
    Dermatol Ther (Heidelb); 2023 Jan; 13(1):115-130. PubMed ID: 36447117
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Nanotechnology-based formulations toward the improved topical delivery of anti-acne active ingredients.
    Paiva-Santos AC; Mascarenhas-Melo F; Coimbra SC; Pawar KD; Peixoto D; Chá-Chá R; Araujo AR; Cabral C; Pinto S; Veiga F
    Expert Opin Drug Deliv; 2021 Oct; 18(10):1435-1454. PubMed ID: 34214003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.